Synthesis and Biological Evaluation of a New Series of 1,2,4-Triazolo[1,5-a]-1,3,5-triazines as Human A2A Adenosine Receptor Antagonists with Improved Water Solubility
Medienart: |
Artikel |
---|
Erscheinungsjahr: |
2011 |
---|---|
Erschienen: |
2011 |
Enthalten in: |
Zur Gesamtaufnahme - volume:54 |
---|---|
Enthalten in: |
Journal of medicinal chemistry - 54(2011), 3 vom: 10. Feb., Seite 877-890 |
Beteiligte Personen: |
Federico, Stephanie [VerfasserIn] |
---|
BKL: |
---|
Umfang: |
13 |
---|
Förderinstitution / Projekttitel: |
|
---|
PPN (Katalog-ID): |
OLC1868903974 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | OLC1868903974 | ||
003 | DE-627 | ||
005 | 20230508112019.0 | ||
007 | tu | ||
008 | 110509s2011 xx ||||| 00| ||und c | ||
028 | 5 | 2 | |a sw110504_1 |
035 | |a (DE-627)OLC1868903974 | ||
035 | |a (DE-599)GBVOLC1868903974 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
082 | 0 | 4 | |a 540 |a 610 |
084 | |a PHARM |2 fid | ||
084 | |a 44.42 |2 bkl | ||
100 | 1 | |a Federico, Stephanie |e verfasserin |4 aut | |
245 | 1 | 0 | |a Synthesis and Biological Evaluation of a New Series of 1,2,4-Triazolo[1,5-a]-1,3,5-triazines as Human A2A Adenosine Receptor Antagonists with Improved Water Solubility |
264 | 1 | |c 2011 | |
300 | |a 13 | ||
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ohne Hilfsmittel zu benutzen |b n |2 rdamedia | ||
338 | |a Band |b nc |2 rdacarrier | ||
700 | 1 | |a Paoletta, Silvia |4 oth | |
700 | 1 | |a Cheong, Siew Lee |4 oth | |
700 | 1 | |a Pastorin, Giorgia |4 oth | |
700 | 1 | |a Cacciari, Barbara |4 oth | |
700 | 1 | |a Stragliotto, Stefano |4 oth | |
700 | 1 | |a Klotz, Karl Norbert |4 oth | |
700 | 1 | |a Siegel, Jeffrey |4 oth | |
700 | 1 | |a Gao, Zhan-Guo |4 oth | |
700 | 1 | |a Jacobson, Kenneth A. |4 oth | |
700 | 1 | |a Moro, Stefano |4 oth | |
700 | 1 | |a Spalluto, Giampiero |4 oth | |
773 | 0 | 8 | |i Enthalten in |t Journal of medicinal chemistry |d Easton, Pa. : American Chemical Society, 1963 |g 54(2011), 3 vom: 10. Feb., Seite 877-890 |w (DE-627)129545201 |w (DE-600)218133-2 |w (DE-576)014995336 |x 0022-2623 |7 nnns |
773 | 1 | 8 | |g volume:54 |g year:2011 |g number:3 |g day:10 |g month:02 |g pages:877-890 |g extent:13 |
912 | |a GBV_USEFLAG_A | ||
912 | |a SYSFLAG_A | ||
912 | |a GBV_OLC | ||
912 | |a FID-PHARM | ||
912 | |a SSG-OLC-CHE | ||
912 | |a SSG-OLC-PHA | ||
912 | |a SSG-OLC-DE-84 | ||
912 | |a SSG-OPC-PHA | ||
912 | |a GBV_ILN_20 | ||
912 | |a GBV_ILN_24 | ||
912 | |a GBV_ILN_70 | ||
912 | |a GBV_ILN_2005 | ||
912 | |a GBV_ILN_2221 | ||
936 | b | k | |a 44.42 |q AVZ |
951 | |a AR | ||
952 | |d 54 |j 2011 |e 3 |b 10 |c 2 |h 877-890 |g 13 |